期刊文献+

外泌体在胃癌发生发展中作用的研究进展 被引量:5

Research progress of exosomes in the occurrence and development of gastric cancer
下载PDF
导出
摘要 外泌体通过胞内体内陷形成多泡体再与质膜融合后释放,其内含有蛋白质、脂质、核酸等生物活性物质。外泌体通过与受体细胞融合,将其内含的生物活性物质作为信号分子传递给受体细胞,从而介导细胞间信号交流。胃癌细胞分泌大量的外泌体,可影响周围细胞的功能,在调控胃癌的生物学行为中发挥重要作用。外泌体在胃癌相关研究中取得较多新进展,包括对胃癌的生长、转移、免疫逃避、耐药性等生物学行为的影响及相关机制,以及作为药物载体在胃癌靶向治疗中的临床应用。
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2018年第11期1154-1158,共5页 Chinese Journal of Cancer Biotherapy
  • 相关文献

参考文献2

二级参考文献45

  • 1Galle J, Sittig D, Hanisch I, Wobus M, Wandel E, Loeffler M,Aust G. Individual cell-based models of tumor-environmentinteractions: Multiple effects of CD97 on tumor invasion. Am JPathol 2006; 169: 1802-1811 [PMID: 17071601 DOI: 10.2353/ajpath.2006.060006].
  • 2Aust G, Steinert M, Schütz A, Boltze C, Wahlbuhl M, HamannJ, Wobus M. CD97, but not its closely related EGF-TM7 familymember EMR2, is expressed on gastric, pancreatic, and esophagealcarcinomas. Am J Clin Pathol 2002; 118: 699-707 [PMID:12428789 DOI: 10.1309/A6AB-VF3F-7M88-C0EJ].
  • 3Martens GJ. Molecular biology of G-protein-coupled receptors.Prog Brain Res 1992; 92: 201-214 [PMID: 1338880 DOI: 10.1016/S0079-6123(08)61176-0].
  • 4Eichler W, Aust G, Hamann D. Characterization of an earlyactivation-dependent antigen on lymphocytes defined by themonoclonal antibody BL-Ac(F2). Scand J Immunol 1994; 39:111-115 [PMID: 8290889 DOI: 10.1111/j.1365-3083.1994.tb03348.x].
  • 5Veninga H, Becker S, Hoek RM, Wobus M, Wandel E, van derKaa J, van der Valk M, de Vos AF, Haase H, Owens B, van der PollT, van Lier RA, Verbeek JS, Aust G, Hamann J. Analysis of CD97expression and manipulation: antibody treatment but not genetargeting curtails granulocyte migration. J Immunol 2008; 181:6574-6583 [PMID: 18941248 DOI: 10.4049/jimmunol.181.9.6574].
  • 6Han SL, Xu C, Wu XL, Li JL, Liu Z, Zeng QQ. The impact ofexpressions of CD97 and its ligand CD55 at the invasion front onprognosis of rectal adenocarcinoma. Int J Colorectal Dis 2010; 25:695-702 [PMID: 20339853 DOI: 10.1007/s00384-010-0926-5].
  • 7Steinert M, Wobus M, Boltze C, Schütz A, Wahlbuhl M, Hamann J,Aust G. Expression and regulation of CD97 in colorectal carcinomacell lines and tumor tissues. Am J Pathol 2002; 161: 1657-1667[PMID: 12414513 DOI: 10.1016/S0002-9440(10)64443-4].
  • 8Aust G, Eichler W, Laue S, Lehmann I, Heldin NE, Lotz O,Scherbaum WA, Dralle H, Hoang-Vu C. CD97: a dedifferentiationmarker in human thyroid carcinomas. Cancer Res 1997; 57:1798-1806 [PMID: 9135025].
  • 9Hoang-Vu C, Bull K, Schwarz I, Krause G, Schmutzler C, AustG, K-hrle J, Dralle H. Regulation of CD97 protein in thyroidcarcinoma. J Clin Endocrinol Metab 1999; 84: 1104-1109 [PMID:10084602].
  • 10Jaspars LH, Vos W, Aust G, Van Lier RA, Hamann J. Tissuedistribution of the human CD97 EGF-TM7 receptor. TissueAntigens 2001; 57: 325-331 [PMID: 11380941 DOI: 10.1034/j.1399-0039.2001.057004325.x].

共引文献35

同被引文献62

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部